Copyright
©The Author(s) 2025.
World J Cardiol. Jan 26, 2025; 17(1): 100886
Published online Jan 26, 2025. doi: 10.4330/wjc.v17.i1.100886
Published online Jan 26, 2025. doi: 10.4330/wjc.v17.i1.100886
Figure 1 Mechanism diagram of sodium-glucose cotransporter 2 inhibitor on different tissues and organs.
NEFA: Nonesterified fatty acids; NHE: Na+/H+ exchanger; CaMK2: Calcium/calmodulin-dependent protein kinase 2; SGLT2i: Sodium-glucose cotransporter 2 inhibitor.
- Citation: Zhang YF, Liu YX, Yang WX. Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure. World J Cardiol 2025; 17(1): 100886
- URL: https://www.wjgnet.com/1949-8462/full/v17/i1/100886.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i1.100886